Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Start-Up Quarterly Statistics, Q2 2010

Sep 01 2010

• By Deanna Kamienski

Related Content

Corporate Venture Strikes Again: Biocartis Lands €30 million--And A Partnership

Apr 10 2010

Clovis And Avila Join In Oncology Drug/Diagnostic Deal

May 25 2010

Sanofi Moves into MicroRNA, Signs Preclinical Platform Deal with Regulus

Jun 22 2010

Tetraphase Raises $45 Mil. In Series C Round, Enough To Finish Phase II For Next-Gen Antibiotic

Jun 01 2010

In Deals With Respivert And Orexo, J&J's Respiratory Push Gets Going

Jun 01 2010

Use Of Protein Biomarkers Punctuates Clovis' Fast-Paced Clinical Trials Strategy

May 01 2010

TetraPhase's Series C

Jun 01 2010

St. Jude Joins with iRhythm in Wireless Cardiac Monitoring

Jun 01 2010

Alnylam, Isis JV Regulus to Tackle MicroRNA

Oct 01 2007

Related Companies

AiCuris Anti-infective Cures GmbH

Bayer AG

Bayer AG

Tetraphase Pharmaceuticals, Inc.

Novelion Therapeutics Inc.

Roche Holding AG

Voyage Medical Inc.

Abbott

Nexeon MedSystems Inc.

Biocartis NV

Debiopharm S.A.

Astute Medical Inc.

Johnson & Johnson

Johnson & Johnson

Johnson & Johnson

GSK plc

IMPERIAL ENTERPRISE DIVISION

Imperial College London

Orexo AB

Adhera Therapeutics, Inc.

Adhera Therapeutics, Inc.

Arbor Pharmaceuticals, LLC

Clovis Oncology, Inc.

Ventana Medical Systems, Inc.

AqualisBraemar ASA

Avila Therapeutics, Inc.

RedHill Biopharma Ltd.

Nualtis

Nutraceutix Inc

Regulus Therapeutics Inc.

Ionis Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc.

University of Wuerzburg

Sanofi

iRhythm Technologies, Inc.

Abbott

Aterovax SA

SPI-Bio

Bertin Technologies group

French National Centre for Scientific Research (CNRS)

Additional Topics

BioPharmaceutical Medical Device

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window